Base de pommade pour la barrière cutanée

1. INCI et CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Rôle dans la formule

Butyrospermum Parkii Butter is listed as a butter in this development reference. The recorded formula also lists Simmondsia Chinensis Seed Oil and Squalane. Review the contribution to body and application feel in the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• Reference component allocation: 28% w/w.

For Butyrospermum Parkii Butter, use an oil-phase melt and shear during cool-down to limit grain formation.

4. Sources réglementaires et conformité mondiale

• This listing is guidance for formula development; it does not constitute approval of the supplied grade or final cosmetic; No approval of the final formula is represented.

5. Sécurité et évaluation des risques

The guide records a level for cosmetic formulation purposes; no drug approval or OTC-monograph status follows from this guide and the final formula should undergo patch and stability assessment.

6. Stabilité et conditionnement

Store sealed bulk away from heat and sunlight; consider an airless or pump format when oxidation sensitivity warrants it; verify the chosen pack against the tested formula.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Butyrospermum Parkii Butter's cosmetic direction around shea cushion.

• The ingredient guidance is not evidence of therapeutic effects, curative outcomes, or unsupported certification statements.
• The cosmetic guidance for Butyrospermum Parkii Butter does not establish skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI et CAS

INCI: Simmondsia Chinensis Seed Oil · CAS: 61789-91-1

2. Rôle dans la formule

Simmondsia Chinensis Seed Oil is listed as an emollient in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Squalane. Review spreading, slip and the finish of the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• Reference component allocation: 16.45% w/w.

The guide places Simmondsia Chinensis Seed Oil in the oil phase.

4. Sources réglementaires et conformité mondiale

• This record describes a development reference; it is not approval of the purchased material or completed cosmetic; It does not establish approval for the finished cosmetic.

5. Sécurité et évaluation des risques

This formulation note gives a cosmetic-use reference level; the note establishes neither drug approval nor OTC-monograph status so assess patch response and stability in the final formula.

6. Stabilité et conditionnement

Keep bulk material sealed, cool, and out of direct sunlight; evaluate packaging against the formula's susceptibility to oxidation; check the finished batch's stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic concept for Simmondsia Chinensis Seed Oil in this entry centers on the jojoba wax-ester role.

• This reference does not demonstrate medical outcomes, cure language, or a product certification not supported by the available facts.
• The ingredient record for Simmondsia Chinensis Seed Oil cannot establish whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

Squalane is listed as an emollient in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Simmondsia Chinensis Seed Oil. Review spreading, slip and the finish of the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The guide level assigned to this component is 14% w/w.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Sources réglementaires et conformité mondiale

• The card records a development guide; it does not certify the supplied material or completed cosmetic; This entry does not approve a completed product.

5. Sécurité et évaluation des risques

This formulation note gives a cosmetic-use reference level; it provides no evidence that a drug or OTC monograph applies so patch response and stability should be checked on the finished product.

6. Stabilité et conditionnement

Use cool, sealed storage away from strong light for the bulk; take oxidation sensitivity into account when selecting the final pack; check the final package and formula together for compatibility and stability.

7. Formulations d'allégations (à faire / à éviter)

• The formulation note describes Squalane as part of a cosmetic direction focused on a light-emollient role.

• The development record does not demonstrate drug effects, clinical cures, or unsupported product certifications.
• This guide to Squalane is not evidence for whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.